|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Bayer Cardiovascular Clinical Research Laboratory (Drs. Mak, Azevedo, and Newton), Department of Medicine, Mount Sinai Hospital, and The Toronto Hospital (Dr. Liu), University of Toronto, Toronto, Ontario, Canada.
Correspondence to: Gary E. Newton, MD, Mount Sinai Hospital, 600 University Ave, Room 1614, Toronto, Ontario, M5G 1X5, Canada; e-mail: gary.newton{at}utoronto.ca
Study objectives: To determine the effects of hyperoxia on left ventricular (LV) function in humans with and without congestive heart failure (CHF).
Design: An acute physiologic
study of the effect of hyperoxia on right-heart hemodynamics, LV
contractility (peak positive rate of rise of LV pressure [+dP/dt]),
time constant of isovolumic left ventricular relaxation (
), and LV
filling pressures.
Setting: Bayer Cardiovascular Clinical Research Laboratory at the Mount Sinai Hospital, Toronto, Ontario.
Patients: Sixteen patients with stable CHF and 12 subjects with normal LV function received the hyperoxia intervention.
Interventions: Patients received 21% O2 by a nonrebreather mask, followed by 100% O2 for 20 min, and 21% O2 for a 10-min recovery period.
Results: In response to hyperoxia,
there was a 22 ± 6% increase in LV end-diastolic pressure (LVEDP)
in the CHF group and a similar 29 ± 14% increase in LVEDP in the
normal LV function group (p < 0.05 for both; mean ± SEM).
Hyperoxia was also associated with a prolongation in
of 10 ± 2%
in the CHF group (p < 0.05) and 8 ± 2% in the normal LV function
group (p < 0.05). No changes in +dP/dt were observed in either
group.
Conclusions: Hyperoxia was associated with impairment of cardiac relaxation and increased LV filling pressures in patients with and without CHF. These observations indicate that caution should be used in the administration of high inspired O2 fractions to normoxic patients, especially in the setting of CHF.
Key Words: congestive heart failure hyperoxia ventricular function
This article has been cited by other articles:
![]() |
A. Garcia-Touchard, V. K. Somers, L. J. Olson, and S. M. Caples Central Sleep Apnea: Implications for Congestive Heart Failure Chest, June 1, 2008; 133(6): 1495 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arzt and T. D. Bradley Treatment of Sleep Apnea in Heart Failure Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1300 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boussuges, F. Blanc, and D. Carturan Hemodynamic Changes Induced by Recreational Scuba Diving Chest, May 1, 2006; 129(5): 1337 - 1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Iscoe and J. A. Fisher Hyperoxia-Induced Hypocapnia: An Underappreciated Risk Chest, July 1, 2005; 128(1): 430 - 433. [Full Text] [PDF] |
||||
![]() |
S. Mak, Z. Egri, G. Tanna, R. Colman, and G. E. Newton Vitamin C prevents hyperoxia-mediated vasoconstriction and impairment of endothelium-dependent vasodilation Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2414 - H2421. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mak, Z. Egri, G. Tanna, R. Colman, and G. E. Newton Vitamin C prevents hyperoxia-mediated vasoconstriction and impairment of endothelium-dependent vasodilation Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2414 - H2421. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |